University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Ceritinib + Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC)

Phase 1

Terminated

Conditions: Non-small Cell Lung Cancer

Interventions: Drug: Ceritinib
Drug: Trametinib

First Posted Date: 2017-03-22

Last Posted Date: 2022-12-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 9

Registration Number: NCT03087448

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
University of California, Davis, Davis, California, United States

Sperm Selection by Microfluidic Separation Improves Embryo Quality

Not Applicable

Completed

Conditions: Infertility Unexplained
Infertility, Male
Fertility Disorders
Embryo Quality
Infertility
Sperm DNA Fragmentation

Interventions: Device: Microfluidic Sperm Sorting
Procedure: in vitro fertilization

First Posted Date: 2017-03-21

Last Posted Date: 2022-11-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 297

Registration Number: NCT03085433

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Improving Engagement in HIV Care for High-risk Women

Not Applicable

Completed

Conditions: HIV/AIDS
Adherence, Medication

Interventions: Behavioral: Healthy Divas

First Posted Date: 2017-03-16

Last Posted Date: 2020-11-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 278

Registration Number: NCT03081559

Locations: 🇺🇸
Alliance Health Project, San Francisco, California, United States
🇺🇸
Friends Community Center, Los Angeles, California, United States

The Relation of GnRH Treatment to QTc Interval in Transgender Females

Terminated

Conditions: Gender Dysphoria

Interventions: Drug: Treatment with a GnRh agonists

First Posted Date: 2017-03-13

Last Posted Date: 2018-12-26

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 3

Registration Number: NCT03078829

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Thalamic Deep Brain Stimulation for Secondary Dystonia in Children and Young Adults

Not Applicable

Completed

Conditions: Dystonia

Interventions: Device: Activa PC Primary Cell Neurostimulator - (Model 37601)
Device: Activa RC Rechargeable Neurostimulator - (Model 37612)
Device: Activa SC Single Cell Neurostimulator (Models 37602/37603)
Device: DBS Lead - (Model 3387
Device: DBS Extension - (Models 37085/6)
Device: Patient Programmer - (Model 37642)
Device: Test Stimulator - (Model 3625)
Device: N'Vision Clinician Programmer - (Model 8840)
Device: N'Vision Software Application Card - (Model 8870)

First Posted Date: 2017-03-13

Last Posted Date: 2020-10-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 5

Registration Number: NCT03078816

Locations: 🇺🇸
University of California San Francisco Hospital, San Francisco, California, United States

Contrast-enhanced Ultrasound Versus CT Scan for Kidney Stone Patient Management

Phase 2

Withdrawn

Conditions: Ultrasonography
Nephrolithiasis

Interventions: Drug: CEUS
Diagnostic Test: Non-contrast CT scan
Diagnostic Test: Capping trial

First Posted Date: 2017-02-23

Last Posted Date: 2022-06-06

Lead Sponsor: University of California, San Francisco

Registration Number: NCT03058614

Inflammation and Threat Sensitivity in PTSD

Early Phase 1

Completed

Conditions: Posttraumatic Stress Disorder

Interventions: Biological: Typhoid Vi Polysaccharide Vaccine
Biological: Placebo

First Posted Date: 2017-02-09

Last Posted Date: 2021-05-13

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT03048929

Locations: 🇺🇸
San Francisco Veterans Affairs Medical Center, San Francisco, California, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States